Emerson Electric Co. (EMR) is a U.S.-based industrial technology company focused on automation, control systems and engineering solutions across multiple industries.
The company provides equipment and software designed to improve operational efficiency and support digital transformation in industrial environments.
Its main activities include:
• Industrial automation and process control solutions.
• Industrial software and monitoring platforms.
• Instrumentation systems for energy, oil and gas and manufacturing.
• Technologies for infrastructure, HVAC and commercial applications.
Emerson serves industries such as energy, oil and gas, chemicals, manufacturing, food and beverages and utilities, with a global presence across North America, Europe and Asia.
Its performance is influenced by industrial investment cycles, global economic conditions, demand for automation and advances in digital industrial technologies.
Emerson Electric Co. trades on the New York Stock Exchange (NYSE) under the ticker EMR.
History and Development
Emerson Electric Co. was founded in 1890 in the United States, initially producing electric motors and industrial equipment.
Over time, the company expanded into multiple industrial segments and built a global presence.
Throughout its history, Emerson strengthened its capabilities in automation and process control technologies.
In recent years, the company has focused on industrial software, digital transformation and advanced automation solutions, aligning with evolving industry demands.
Additional Information
Emerson Eletric Company (United States) is listed on the NYSE and has a market capitalization of $80.36 Billions, with shareholders equity totaling $20.32 Billions.
The company employs approximately 83.500 people and operates in the Technology sector, within the Scientific and Technical Instruments industry.
Over the past 12 months, Emerson Eletric Company reported $18.32 Billions in revenue, generating net income of $2.45 Billions.
Key financial metrics include a P/E ratio of 32.87, a price-to-book (P/B) ratio of 3.95, and a trailing twelve-month dividend yield of 1.51%.
The company trades under the ticker EMR.